Amisulpride

The recommended dosage of BARHEMSYS: Prevention of PONV, either alone or in combination with another antiemetic: 5 mg as a single intravenous dose infused over 1 to 2 minutes at the time of induction of anesthesia. Treatment of PONV: 10 mg as a single intravenous dose infused over 1 to 2 minutes in the event of nausea and/or vomiting after a surgical procedure. See full prescribing information for preparation and administration instructions.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

BARHEMSYS is contraindicated in patients with known hypersensitivity to amisulpride. Known hypersensitivity to amisulpride.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

QT Prolongation: Occurs in a dose- and concentration-dependent manner. Avoid use in patients with congenital long QT syndrome and in patients taking droperidol. ECG monitoring is recommended in patients with pre-existing arrhythmias/cardiac conduction disorders; electrolyte abnormalities (e.g., hypokalemia or hypomagnesemia); congestive heart failure; and in patients taking other medicinal products (e.g., ondansetron) or with other medical conditions known to prolong the QT interval. 5.1 QT Prolongation BARHEMSYS causes dose- and concentration-dependent prolongation of the QT interval.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

Most common adverse reactions (≥ 2%) are: Prevention of PONV: increased blood prolactin concentrations, chills, hypokalemia, procedural hypotension, and abdominal distension. Treatment of PONV: infusion site pain. To report SUSPECTED ADVERSE REACTIONS, contact Acacia Pharma at 1-877-357-9237 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

377 products from 139 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 377 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Store vials at 20°C to 25°C (68°F to 77°F). Protect from light. Administer BARHEMSYS within 12 hours after the vial is removed from the protective carton.

Storage information from the U.S. FDA-approved label.